- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04116281
Short and Long Term Effects of a Physical Therapy Program After Breast Cancer Surgery
July 9, 2022 updated by: Ivana Leão Ribeiro, Universidade Federal de Sao Carlos
Study of the Possible Sensory, Biomechanical, Cardiorespiratory and Quality of Life Adaptations Associated With Physical Therapy Rehabilitation in the Short and Long Term Postoperative of Breast Cancer
Objectives: To evaluate the pressure pain threshold, shoulder biomechanics, cardiorespiratory function and the quality of life associated with the short and long-term physical therapy rehabilitation following breast cancer surgery.
Methodology: The study presents three objectives and involves three groups of participants.
Objective 1 is to develop a topographic map of pressure pain in the shoulder (using a digital pressure algometer), evaluate the biomechanics of the shoulder (using a digital inclinometer and load card), cardiorespiratory function (through frequency variability resting heart rate and distance traveled, through the six-minute walk test) and quality of life (through questionnaires of quality of life, anxiety, depression, sleep quality, upper limb functionality, fatigue and level of physical activity) between a group of women prior to the operation of breast cancer (experimental group, n = 36) and a group of asymptomatic controls for shoulder pain (control group, n = 18).
Objective 2 is to evaluate the possible changes in the pain map over 24 weeks of supervised kinetic intervention (Supervised Physiotherapy experimental group, n = 18, will begin after drainage, frequency 3 times per week and duration of 60 minutes each session) compared to unsupervised kinetic intervention (Home Physiotherapy experimental group, n = 18, participants will receive an exercise booklet).
Objective 3 is to evaluate the biomechanics of the shoulder, cardiorespiratory function and the quality of life with respect to the experimental group with and without kinesic supervision.
To achieve objective 1, two baseline evaluations will be carried out in both experimental and control groups (considering the month prior to the surgery of the experimental group) and the average of the evaluations will be considered evaluation 1.
To achieve objectives 2 and 3, evaluation 2 (after 4 weeks of intervention), 3 (after 12 weeks of intervention) and 4 (after 24 weeks of intervention) will be performed.
The statistical analysis will include the examination of qualitative and quantitative variables.
Statistical tests will be applied according to the normality of the data and a significance level of 5% will be adopted for all comparisons.
Expected results: It is expected to identify sensory, biomechanical, cardiorespiratory and quality of life alterations in the experimental group, compared to the control group.
In addition, after 24 weeks of intervention, the supervised experimental group will show improvement in all the aforementioned variables with respect to the unsupervised group.
Study Overview
Status
Suspended
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maule
-
Talca, Maule, Chile, 3600000
- Catholic University of Maule
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Surgical indication of conservative or removal breast surgery, associated with axillary lymphadenectomy or sentinel lymph node biopsy
- Any type of breast cancer
- Age range over 18 years
Exclusion Criteria:
- Breast cancer recurrence;
- Surgical treatment for bilateral breast cancer;
- Presence of lymphedema in the upper limb, measured by means of cirtometry of the upper limb with a measuring tape 14, asymmetries of more than 1.5 cm between the limbs were considered edema;
- Diagnosis of metastases;
- Shoulder pain compatible with shoulder compression symptoms as determined by the positive Hawkins-Kennedy test 30;
- Previous history of surgery and fractures in the upper extremities.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Supervised group
|
All participants are going to receive physical therapy intervention after breast cancer surgery at least removal drenaige.
After that, will be randomized in two groups: Group 1 are going to receive a physical therapy program supervised by a physiotherapist; Group 2 are going to receive some instructions about the same program to perfomr at home without supervision.
Both groups are going to receive 3 and 6 months of rehabilitation program.
|
|
Other: No supervised group
Control group
|
All participants are going to receive physical therapy intervention after breast cancer surgery at least removal drenaige.
After that, will be randomized in two groups: Group 1 are going to receive a physical therapy program supervised by a physiotherapist; Group 2 are going to receive some instructions about the same program to perfomr at home without supervision.
Both groups are going to receive 3 and 6 months of rehabilitation program.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure pain threshold over the shoulder of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to pressure pain threshold assessment over the shoulder at three and six monthes of treatment.
|
Three months
|
|
Pressure pain threshold over the shoulder of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to pressure pain threshold assessment over the shoulder at three and six monthes of treatment.
|
Six months
|
|
Strength grip of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to objective measurement that consist in to do a maximal strenth grip.
The unity of measurement it is in kg.
|
Three months
|
|
Strength grip of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to objective measurement that consist in to do a maximal strenth grip.
The unity of measurement it is in kg.
|
Six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Upper limb functionality of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to a questionnaire of upper limb function during activity daily routine.
The questionnaire has 33 questions and each one has 5 posible answers.
|
Three months
|
|
Upper limb functionality of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to a questionnaire of upper limb function during activity daily routine.
The questionnaire has 33 questions and each one has 5 posible answers.
|
Six months
|
|
Fatigue of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to a questionnaire wich contains 9 preguntas and 10 differente posibilities of answers.
|
Three months
|
|
Fatigue of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to a questionnaire wich contains 9 questions and 10 different posibilities of answers.
|
Six months
|
|
Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to functional capacity performed wiht the walking test measured by the distance performed after a walking.
|
Three months
|
|
Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to functional capacity performed wiht the walking test measured by the distance performed after a walking.
|
Six months
|
|
Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to heart rate variability measured with a Polar and reloj in a supine and orthostatic posture
|
Three months
|
|
Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to heart rate variability measured with a Polar and reloj in a supine and orthostatic posture
|
Six months
|
|
Quality of life of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Three months
|
This outcome will involve data regarding to a questionnaire of quality of life regarding symptoms of chemotherapy that affects on quality of life perception.
The questionnaire has 53 questions and each one has 4 posible answers.
|
Three months
|
|
Quality of life of breast cancer patients after a physical therapy rehabilitation program following the surgery.
Time Frame: Six months
|
This outcome will involve data regarding to a questionnaire of quality of life regarding symptoms of chemotherapy that affects on quality of life perception.
The questionnaire has 53 questions and each one has 4 posible answers.
|
Six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ivana L Ribeiro, PhD, Universidad Católica del Maule
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 2, 2019
Primary Completion (Actual)
May 30, 2020
Study Completion (Anticipated)
February 25, 2024
Study Registration Dates
First Submitted
September 29, 2019
First Submitted That Met QC Criteria
October 2, 2019
First Posted (Actual)
October 4, 2019
Study Record Updates
Last Update Posted (Actual)
July 12, 2022
Last Update Submitted That Met QC Criteria
July 9, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 154/2019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Cancer
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Northwestern UniversityEisai Inc.UnknownMale Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative...United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of Colorado, DenverCompletedStage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerCanada
-
Mayo ClinicMarker Therapeutics, Inc.CompletedHER2-positive Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of Central FloridaFlorida Department of HealthRecruitingBreast Cancer | Breast Cancer Female | Breast Cancer Diagnosis | Breast Cancer Survivors | Breast Cancer Detection | Breast Cancer AwarenessUnited States
Clinical Trials on Rehabilitation after breast cancer surgery
-
Jules Bordet InstituteCompletedInvasive Breast CancerBelgium
-
MGH Institute of Health ProfessionsRecruiting
-
Ankara Etlik City HospitalRecruitingBreast Surgery | Pain, Acute | Breast Cancer Surgery | Pain, Chronic | MastectomyTurkey
-
The Greater Poland Cancer CentreActive, not recruiting
-
University of NebraskaUniversity of Kansas Medical CenterCompletedBreast Cancer | Psychological AdjustmentUnited States
-
University of NebraskaCompletedBreast CancerUnited States
-
Northeastern UniversityAmerican Physical Therapy AssociationCompletedBreast Cancer
-
Northwestern UniversityLynn Sage Breast Cancer Research FoundationCompletedBreast Cancer Female
-
Danish Pain Research CenterDOLORisk Consortium; Aarhus University HospitalCompletedChronic Neuropathic Pain, Postoperative | Chronic Pain, Postoperative | Chronic Chemotherapy-induced Neuropathic Pain | Chronic Chemotherapy-induced Pain | Chronic Chemotherapy-induced Peripheral NeuropathyDenmark
-
CairnSurgical, Inc.CompletedBreast CancerGermany, Switzerland, Italy